Background: To evaluate new psoriasis treatments, clinicians, regulators and pharmaceutical
developers require well-accepted, clinically meaningful measures of disease severity. The …

… Dr Langley has served as an investigator for Abbott, Amgen, Centocor, Celgene, Pfizer,
Johnson & Johnson/Ortho Biotech, and Novartis; as a speaker for Abbott, Amgen, Centocor, …

Background: The ascomycin derivative pimecrolimus (ASM 981) is a cell-selective cytokine
inhibitor, specifically developed for the treatment of inflammatory skin diseases. Objective: …

Background: Differentiation of melanoma from melanocytic nevi is difficult even for skin
cancer specialists. This motivates interest in computer-assisted analysis of lesion images. …

Background: The ability of physicians for early diagnosis of cutaneous melanomas is less
than perfect, prompting research into noninvasive methods for diagnosis. Objective: Our …

Background: The diagnosis of melanoma at an early, curable stage is an important
challenge for clinicians. Confocal scanning laser microscopy (CSLM) is a high-resolution, …

Changes in body weight and the incidence of estrogen-related side effects with low-dose oral
contraceptives (OCs) containing 20 μg ethinyl estradiol (EE) have not been demonstrated …

BACKGROUND: An important challenge facing clinicians is recognizing and distinguishing
benign pigmented lesions from cutaneous melanoma. Lentigines are a type of benign …

A 71-year-old man presented with an acute onset of multiple white papules on the face and
chest. Histologic sections demonstrated multiple milia. The rare condition of multiple eruptive …

INTRODUCTION The incidence of cutaneous melanoma is increasing at a greater rate than
any other malignancy in men and is second only to lung cancer in women (1). In the United …